Parla Pharmaceuticals, the first Azerbaijani scientifically based pharmaceutical company, held a meeting with the country’s leading endocrinologists on the production of endocrinological drugs.
In order to support the production of high -quality drugs in Azerbaijan, Parla Pharmaceuticals held a meeting of the endocrinological advisory council with the support of the Scientific Society of Endocrinologists of Azerbaijan and the Azerbaijani Diabetic Society. The leading endocrinologists of the country, as well as the chairman of the Azerbaijani Diabetic Society, gave the company their recommendations for the release of new endocrinological drugs of the company “Parla Pharmaceuticals” on the market, and also exchanged views on this.
“One of the main goals of local production of drugs is to reduce the dependence on imports and make the drugs available to all patients. There is currently a great need for local production in our country. Parla Pharmaceuticals preparations are undergoing strict inspections and research From the Ministry of Health of the Azerbaijan Republic, so we are completely confident in their quality and security, ”said the chief endocrinologist of the Ministry of Health Babek Salel Gannadi during the meeting.
“Local production of drugs is a great progress for our country. According to our information, the drugs” Parla Pharmaceuticals “are effective and safe in use, which is very important for us doctors. The presence of domestic drugs is huge assistance to the country’s economy and healthcare, ”added during the meeting the chairman of the scientific society of endocrinologists of Azerbaijan, Professor Valekh Mirza -Zade.
Endocrinologist of the clinic “Hb Güven” Gyulai Gasan Gyzy noted that the grocery portfolio of Parla Pharmaceuticals includes both biotechnological and nanotechnological and classical drugs: “This is a great opportunity for our country. Thus, Azerbaijan will be included in Azerbaijani The number of few countries of the world producing drugs for high technologies. ” Gyulai Hasan Gyzy believes that the production of these drugs will have a huge impact on improving the quality of life of patients in Azerbaijan.
As for the production of biotechnological drugs, Parla Pharmaceuticals is currently negotiating with a number of leading companies in the world to expand their innovative activities through technology transfers. In addition to the sale of company drugs in Azerbaijan, their exports are also planned to many countries and mutual export opportunities.